We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-4.28%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.1B
AUM Growth
-$154M
(-0.76%)
Cap. Flow
+$988M
Cap. Flow
% of AUM
4.91%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
777
New
61
Increased
377
Reduced
301
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$252M |
| 2 |
Nutrien
NTR
|
+$196M |
| 3 |
B
Barrick Mining
B
|
+$180M |
| 4 |
Franco-Nevada
FNV
|
+$165M |
| 5 |
GG
Goldcorp Inc
GG
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$169M |
| 2 |
Union Pacific
UNP
|
+$63.1M |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$43M |
| 4 |
CPE
Callon Petroleum Company
CPE
|
+$38.5M |
| 5 |
Louisiana-Pacific
LPX
|
+$31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 51.82% |
| 2 | Energy | 17.22% |
| 3 | Healthcare | 6.47% |
| 4 | Technology | 5.7% |
| 5 | Consumer Discretionary | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
ON Semiconductor
ON
$34.7B
| $23.6M | 0.12% |
966,701
+175,196
| +22% | +$4.22M |
|
152
Marvell Technology
MRVL
$170B
| $23.3M | 0.12% |
1,110,912
+149,191
| +16% | +$3.42M |
|
|
GSV
153
DELISTED
Gold Standard Ventures Corp.
GSV
| $22.8M | 0.11% |
13,967,181
+283,216
| +2% | +$479K |
|
154
Sunrun
RUN
$2.38B
| $22.6M | 0.11% |
2,525,146
-66,100
| -3% | -$446K |
|
|
INVX
155
Innovex International
INVX
$1.85B
| $22.4M | 0.11% |
499,969
+24,071
| +5% | +$1.18M |
|
156
Ormat Technologies
ORA
$6.28B
| $21.8M | 0.11% |
386,501
+333,403
| +628% | +$20.8M |
|
157
Vertex Pharmaceuticals
VRTX
$122B
| $21.7M | 0.11% |
133,105
-56,839
| -30% | -$9.28M |
|
158
VEON
VEON
$3.58B
| $21.4M | 0.11% |
324,803
-5,989
| -2% | -$502K |
|
159
Regeneron Pharmaceuticals
REGN
$69.9B
| $21M | 0.1% |
61,064
-8,479
| -12% | -$2.95M |
|
160
Nike
NKE
$62.5B
| $20.9M | 0.1% |
314,173
+36,413
| +13% | +$2.4M |
|
|
CNR
161
Core Natural Resources Inc
CNR
$4.16B
| $20.5M | 0.1% |
708,774
-18,590
| -3% | -$599K |
|
|
KLDX
162
DELISTED
KLONDEX MINES LTD
KLDX
| $20.5M | 0.1% |
8,737,176
-4,957,549
| -36% | -$9.5M |
|
|
DO
163
DELISTED
Diamond Offshore Drilling
DO
| $20.5M | 0.1% |
1,399,788
-40,098
| -3% | -$662K |
|
164
The Mosaic Company
MOS
$7.1B
| $20.1M | 0.1% |
827,401
+81,160
| +11% | +$2.13M |
|
165
Veeva Systems
VEEV
$31.6B
| $20.1M | 0.1% |
274,766
-335,219
| -55% | -$21.7M |
|
166
Illumina
ILMN
$28.7B
| $20M | 0.1% |
86,756
-38,284
| -31% | -$8.77M |
|
167
FMC
FMC
$1.39B
| $19.9M | 0.1% |
299,712
+4,014
| +1% | +$299K |
|
168
John Wiley & Sons Class A
WLY
$2.59B
| $19.9M | 0.1% |
311,894
+37,940
| +14% | +$2.46M |
|
169
IQVIA
IQV
$35.6B
| $19.8M | 0.1% |
202,315
-57,539
| -22% | -$5.82M |
|
170
Goldgroup Mining Inc.
GORO
$162M
| $19.3M | 0.1% |
4,272,515
+133,713
| +3% | +$602K |
|
171
BioMarin Pharmaceuticals
BMRN
$11.6B
| $19.2M | 0.1% |
237,412
-41,194
| -15% | -$3.54M |
|
|
ALXN
172
DELISTED
Alexion Pharmaceuticals
ALXN
| $19.2M | 0.1% |
172,056
-66,585
| -28% | -$7.96M |
|
173
Dominion Energy
D
$61.8B
| $18.8M | 0.09% |
279,308
+251,378
| +900% | +$18.6M |
|
174
Fomento Económico Mexicano
FMX
$45B
| $18.7M | 0.09% |
204,965
-44,125
| -18% | -$4.13M |
|
175
McDonald's
MCD
$192B
| $18.7M | 0.09% |
+119,573
| New | +$19.7M |
|
Similar funds
DAM
VanEck Associates's Q1 2018 Portfolio in Review
As of Q1 2018, VanEck Associates held 777 positions worth $20.1B, down 0.76% from $20.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
VanEck Associates deployed $988M of net new capital in Q1 2018, opening 61 new positions and adding to 377 existing holdings. Its largest new stake was Nutrien: 3,920,000 shares worth $185M.
By sector, the portfolio is most concentrated in Materials at 52% of assets, up from 50% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Louisiana-Pacific, an estimated $31M trimmed.
- VanEck Associates's largest Q1 2018 buy was Nutrien: 3,920,000 shares worth $185M.
- VanEck Associates added most to Newmont in Q1 2018, an estimated $252M increase.
- VanEck Associates's biggest Q1 2018 reduction was Louisiana-Pacific, cutting an estimated $31M.
- VanEck Associates fully exited Agrium in Q1 2018, selling an estimated $169M.
- VanEck Associates's ten largest holdings make up 28% of its $20.1B portfolio in Q1 2018.
- VanEck Associates opened 61 new positions and closed 33 in Q1 2018.
- VanEck Associates's portfolio value fell 0.76% quarter-over-quarter to $20.1B.
Based on VanEck Associates's 13F filing for Q1 2018, filed 11 May 2018.